These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12685623)

  • 41. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Choice of stenting strategy in true coronary artery bifurcation lesions.
    Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
    Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative trial of stent-like balloon angioplasty versus coronary stenting for acute myocardial infarction.
    Eid-Lidt G; Villavicencio-Fernández R; Ponce-De-León-Rosales S; Gaspar J; Luna-Guerra J; Ban-Hayashi E; Peña-Duque MA; Martinez-Rios MA
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):149-54. PubMed ID: 11387597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasminogen activator inhibitor-1 and restenosis.
    Garg N; Fay WP
    Curr Drug Targets; 2007 Sep; 8(9):1003-6. PubMed ID: 17896951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
    Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
    Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators.
    Maillard L; Hamon M; Khalife K; Steg PG; Beygui F; Guermonprez JL; Spaulding CM; Boulenc JM; Lipiecki J; Lafont A; Brunel P; Grollier G; Koning R; Coste P; Favereau X; Lancelin B; Van Belle E; Serruys P; Monassier JP; Raynaud P
    J Am Coll Cardiol; 2000 Jun; 35(7):1729-36. PubMed ID: 10841218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group.
    Meneveau N; Bassand JP; Bauters C; Rozand JY; Petit JL; Beurrier D; Grollier G; Andre F; Vahanian A; Viel JF
    Eur Heart J; 1997 Aug; 18(8):1261-8. PubMed ID: 9458418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
    Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
    Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of the AngioJet in patients with acute myocardial infarction: results from the Florence Appraisal Study of Rheolytic Thrombectomy (FAST).
    Margheri M; Falai M; Vittori G; Zoccai GG; Chechi T; Ricceri I; Falchetti E; Comeglio M; Giglioli C; Valente S; Gensini GF
    J Invasive Cardiol; 2006 Oct; 18(10):481-6. PubMed ID: 17235420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary angioplasty in acute myocardial infarct with or without a stent implant: the experience and results at 6 months in the first 200 patients].
    Galli M; Zerboni S; Politi A; De Nittis G; Bonatti R; Jemoli R; Molteni S; Tettamanti F; Ferrari G
    G Ital Cardiol; 1999 Mar; 29(3):261-8. PubMed ID: 10231671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing.
    Park SJ; Lee CW; Kim YH; Lee JH; Hong MK; Kim JJ; Park SW
    Am J Cardiol; 2002 Aug; 90(4):374-8. PubMed ID: 12161225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonrandomized comparison between stent deployment and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
    Katz S; Green SJ; Kaplan BM; Chepurko L; Goldner BG; Ong L
    Am Heart J; 2000 Jan; 139(1 Pt 1):44-51. PubMed ID: 10618561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
    Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
    Ribichini F; Wijns W; Ferrero V; Matullo G; Camilla T; Feola M; Guarrera S; Vado A; Piazza A; Uslenghi E
    Am J Cardiol; 2003 Jan; 91(2):154-8. PubMed ID: 12521626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
    Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
    Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter randomized comparison of direct vs. conventional stenting: the DIRECTO trial.
    Ballarino MA; Moreyra E; Damonte A; Sampaolesi A; Woodfield S; Pacheco G; Caballero G; Picabea E; Baccaro J; Tapia L; Lascano ER
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):434-40. PubMed ID: 12652489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting.
    Ellis SG; Lincoff AM; Whitlow PL; Raymond RE; Franco I; Schneider JP; Topol EJ
    Am J Cardiol; 2002 Apr; 89(8):937-40. PubMed ID: 11950431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One-week and six-month angiographic controls of stent implantation after occlusive and nonocclusive dissection during primary balloon angioplasty for acute myocardial infarction.
    Spaulding C; Cador R; Benhamda K; Ali OS; Garcia-Cantu E; Monsegu J; Py A; Weber S
    Am J Cardiol; 1997 Jun; 79(12):1592-5. PubMed ID: 9202346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.